Hugel マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Ji-hoon Sohn

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	6.8yrs
CEOの所有権	n/a
経営陣の平均在職期間	6.8yrs
取締役会の平均在任期間	2.6yrs

経営陣の近況

Recent updates

Hugel (KOSDAQ:145020) Has A Rock Solid Balance Sheet

Oct 19

An Intrinsic Calculation For Hugel, Inc. (KOSDAQ:145020) Suggests It's 39% Undervalued

Sep 13

Are Hugel, Inc.'s (KOSDAQ:145020) Mixed Financials Driving The Negative Sentiment?

Mar 19

What Is The Ownership Structure Like For Hugel, Inc. (KOSDAQ:145020)?

Feb 25

Does Hugel (KOSDAQ:145020) Have A Healthy Balance Sheet?

Feb 04

The Hugel (KOSDAQ:145020) Share Price Has Gained 197%, So Why Not Pay It Some Attention?

Jan 17

Does Hugel's (KOSDAQ:145020) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 29

Does This Valuation Of Hugel, Inc. (KOSDAQ:145020) Imply Investors Are Overpaying?

Dec 14

How Many Hugel, Inc. (KOSDAQ:145020) Shares Do Institutions Own?

Nov 24

CEO（最高経営責任者

Ji-hoon Sohn

6.8yrs

在職期間

Mr. Ji-hoon Sohn has been Chief Executive Officer of Hugel, Inc. since 2018. He served as Co-Chair of the Board of Directors at Hugel, Inc. and serves as its Director since March 2018. He served as Chief E...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Ji-hoon Sohn	CEO & Executive Director	6.8yrs	データなし	データなし
J. T. Kim	MD & CFO	5.8yrs	データなし	データなし
Seonho Han	VP and Chief Sales & Marketing Officer	6.8yrs	データなし	データなし
Soon-Woo Kwon	VP & Chief Production Officer	13.8yrs	データなし	データなし
Jennifer Rho	MD & Chief Strategy Officer	no data	データなし	データなし
Minjong Kang	MD & Head of Marketing	5.8yrs	データなし	データなし
Jihye Song	MD & Head of Cosmetics	6.8yrs	データなし	データなし
Young Mahn Yoo	MD & Chief Production Officer	no data	データなし	データなし

6.8yrs

平均在職期間

経験豊富な経営陣: A145020の経営陣は経験豊富で経験豊富です（平均在職期間は6.8年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Ji-hoon Sohn	CEO & Executive Director	6.7yrs	データなし	データなし
Brenton L. Saunders	Non-Executive Chairman of the Board of Directors & Chair of Advisory Board	2.5yrs	データなし	データなし
Michael Keyoung	Non-Executive Director	2.6yrs	データなし	データなし
Patrick Holt	Independent Director	2.6yrs	データなし	データなし
Suh Hur	Non-Executive Director	2.6yrs	データなし	データなし
Tae Hyoung Lee	Non-Executive Director	2.6yrs	データなし	データなし
Seungmin Chee	Independent Director	2.6yrs	データなし	データなし
Suk-yong Cha	Non-Executive Director	1.7yrs	データなし	データなし

2.6yrs

平均在職期間

51.5yo

平均年齢

経験豊富なボード: A145020の取締役会は経験豊富ではない ( 2.6年の平均在任期間) ため、新しい取締役会が必要であると考えられます。

Hugel マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Less than half of directors are independent

Hugel, Inc. Appoints Brent Saunders to its Board of Director

No independent directors

Hugel, Inc., Annual General Meeting, Mar 26, 2021

Recent updates

Price target increased by 7.3% to ₩352,545

Investor sentiment improves as stock rises 17%

Hugel, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Hugel (KOSDAQ:145020) Has A Rock Solid Balance Sheet

Investor sentiment improves as stock rises 16%

An Intrinsic Calculation For Hugel, Inc. (KOSDAQ:145020) Suggests It's 39% Undervalued

Consensus EPS estimates increase by 13%

Price target increased by 7.2% to ₩279,444

There's Reason For Concern Over Hugel, Inc.'s (KOSDAQ:145020) Price

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued

Hugel, Inc. to Report Q2, 2024 Results on Aug 07, 2024

Price target increased by 13% to ₩254,889

Investor sentiment improves as stock rises 21%

Estimating The Intrinsic Value Of Hugel, Inc. (KOSDAQ:145020)

Now 21% undervalued

Now 22% undervalued

Hugel, Inc. to Report Q1, 2024 Final Results on May 09, 2024

Hugel (KOSDAQ:145020) Seems To Use Debt Rather Sparingly

Hugel's (KOSDAQ:145020) Performance Is Even Better Than Its Earnings Suggest

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Now 23% undervalued

Hugel, Inc.'s (KOSDAQ:145020) 25% Price Boost Is Out Of Tune With Earnings

Calculating The Fair Value Of Hugel, Inc. (KOSDAQ:145020)

Investor sentiment improves as stock rises 19%

Price target increased by 8.7% to ₩201,750

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Consensus EPS estimates increase by 38%

Price target increased by 8.1% to ₩172,571

Hugel Resubmits BLA for Its Botulinum Toxin, Letybo to the U.S. Fda

Price target decreased by 8.8% to ₩159,250

Hugel, Inc. (KOSDAQ:A145020) acquired additional 3.13% stake in Across Co., Ltd for KRW 9.385 billion.

Investor sentiment deteriorates as stock falls 18%

Price target increased by 7.3% to ₩189,714

Investor sentiment deteriorates as stock falls 18%

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Now 29% undervalued

Now 20% undervalued

Investor sentiment improved over the past week

Hugel's 'Letybo' First in Korea to Obtain Marketing Approval from Australia

Less than half of directors are independent

Consensus forecasts updated

Investor sentiment improved over the past week

Price target decreased to ₩194,875

Hugel, Inc. Appoints Brent Saunders to its Board of Director

No independent directors

Hugel, Inc. (KOSDAQ:A145020) announces an Equity Buyback for KRW 50,000 million worth of its shares.

Price target decreased to ₩214,889

Investor sentiment deteriorated over the past week

Price target decreased to ₩238,333

Consensus EPS estimates fall by 10%

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Are Hugel, Inc.'s (KOSDAQ:145020) Mixed Financials Driving The Negative Sentiment?

What Is The Ownership Structure Like For Hugel, Inc. (KOSDAQ:145020)?

New 90-day low: ₩174,400

Hugel, Inc. Announces Approval to Launch of Letybo 50U in Prc Market

Hugel, Inc., Annual General Meeting, Mar 26, 2021

Does Hugel (KOSDAQ:145020) Have A Healthy Balance Sheet?

Hugel, Inc. to Report Fiscal Year 2020 Results on Feb 09, 2021

Investor sentiment improved over the past week

New 90-day high: ₩224,700

The Hugel (KOSDAQ:145020) Share Price Has Gained 197%, So Why Not Pay It Some Attention?

Price target raised to ₩251,818

Does Hugel's (KOSDAQ:145020) Statutory Profit Adequately Reflect Its Underlying Profit?

Does This Valuation Of Hugel, Inc. (KOSDAQ:145020) Imply Investors Are Overpaying?

New 90-day low: ₩175,600

How Many Hugel, Inc. (KOSDAQ:145020) Shares Do Institutions Own?

Price target raised to ₩241,515

Price target raised to ₩227,788

マネジメント基準チェック /14